Non-alcoholic steatohepatitis: Natural history and diagnosis;Stéoto-hépatite non alcoolique: Histoire naturelle et diagnostic

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 8-9, 2003, Pages 793-798

  Larrey, Dominique ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FATTY LIVER; HEPATITIS; HISTOPATHOLOGY; HISTORY; LIVER BIOPSY; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; PROGNOSIS; REVIEW; RISK FACTOR;

EID: 0141683847     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Larrey D. De la stétose hépatique de l'obèse à la cirrhose, en l'absence d'intoxication alcoolique. Presse Med 2003;32:512-8.
2. e Ed. Médecine-Sciences Flammarion 2000;64-7.
3. nd edn, vol II, Oxford University Press 1999;1252-6.
4. Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis. Mayo Clin Proc 1980;55:434-8.
5. James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999;353:1634-6.
6. Diehl AM. Nonalcoholic steatohepatitis. Sem Liv Dis 1999;19:221-9.
7. Petit P, Zarski JP. Les stéato-hépatites non alcooliques. Gastroenterol Clin Biol 2000;2:157-9.
8. Brunt EM. Nonalcoholic steatohepatitis: definition and patology. Semin Liv Dis 2001;21:3-16.
9. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Sem Liv Dis 2001;21:17-26.
10. Bellantani S, Tiribelli C. The spectrum of liver disease in the general population: the lesson of Dionysos study. J Hepatol 2001;35:531-7.
11. Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Sem Liv Dis 2001;21:71-80.
12. Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver funtion tests in the absence of diagnosiic serology. J Hepatol 2001;35:195-9.
13. De Ledinghen V, Combes M, Troette H, Winnock M, Amouretti M, de Mascarel A, et al. Faut-il faire une ponction-biopsie hépatique lors du bilan de cytolyses chroniques inexpliquées? (résumé). Gastroenterol Clin Biol 1999;23:971.
14. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Sem Liv Dis 2001;21:27-41.
15. Oppert JM, Rolland-Cachera MF. Prévalence, évolution dans le temps et conséquences économiques de l'obésité. Medecine/Sciences 1998;14:939-43.
16. Basdevant A, Laville M, Ziegler O. Guide pratique pour le diagnostic, la prévention. le traitement des obésités en France. Diabetes Metab 1988;24 (suppl.2):10-42.
17. Charles MA. Actualités épidémiologiques de l'obésité et du diabète de type 2 en France. Diabetes & Metabolism 2000;26:17-20.
18. Larrey D. Pathologies hépatiques mitochondriales. Gastroenterol Clin Biol 2001;25:B117-22.
19. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Sem Liv Dis 2001;21:57-69.
20. Angulo P, Keach JC, Kennetti PB, Lindo KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62.
21. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver, fibrosis in overweight patients. Gastroenterology 2000;118:1117-23.
22. Poonawala A, Nair SP, Thuluwath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000;32:689-92.
23. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2000;35:1485-93.
24. Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999;31:421-9.
25. George DK, Goldwurm, McDonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-8.
26. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349:95-7.
27. Angulo P, Lindor KD. Insulin resistance and mitochonfrial abnormalities in NASH: a cool look into a burning issue. Gastroenterology 2001;120:1281-5.
28. Sanyal AJ, Campbell-Sargent C, Mirshhi F, Rizzo WB, Contos M, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-92.
29. Younossi ZM, Gramlich T, Bacon BR, Matteoni CA, Boparal N, O'Neil R, et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology 1999;30:847-50.
30. Garcia-Monzon C, Martin-Perez E, Lo Iacono O, Fernandez-Bermejo M, Majano PL, Apolinario A, et al. Characterization of pathogenic and pronostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 2000;33:716-24.
31. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.